Neoadjuvant therapy and vascular resection during pancreaticoduodenectomy: Shifting the survival curve for patients with locally advanced pancreatic cancer

World Journal of Surgery

Volumn 38, Issue 5, 2014, Pages 1184-1195

  Epelboym, Irene ^a   Dinorcia, J ^a   Winner, M ^a   Lee, M K ^a   Lee, J A ^a   Schrope, B A ^a   Chabot, J A ^a   Allendorf, J D ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; AGED; CANCER STAGING; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL RATE; VASCULAR SURGERY;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RETROSPECTIVE STUDIES; SURVIVAL RATE; VASCULAR SURGICAL PROCEDURES;

EID: 84898894482     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2384-z     Document Type: Article

References (27)

1. Jemal A, Siegel R, Xu J et al (2010) Cancer statistics. CA Cancer J Clin 60:277-300
2. Raimondi S, Masionneuve P, Lowenfels AB (2009) Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 6:699-708
3. Arvold ND, Ryan DP, Niemierko A et al (2011) Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer. Cancer 18:3026-3035
4. Wanebo HJ, Glicksman AS, Vezeridis MP et al (2000) Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg 135:81-87
5. Chua TC, Saxena A (2010) Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg 14:1442-1452
6. Martin RCG, Scoggins CR, Egnatashvili V et al (2009) Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes. Arch Surg 144:154-159
7. Jia Y, Wang TJC, Allendorf J et al (2012) Management of borderline resectable pancreatic adenocarcinoma: highlights from the 2012 ASCO gastrointestinal cancers symposium. JOP 13:147-150
8. Tucker ON, Rela M (2008) Controversies in the management of borderline resectable proximal pancreatic adenocarcinoma with vascular involvement. HPB Surg. doi: 10.1155/2008/839503
9. Evans DB, Farnell MB, Lillemoe KD et al (2009) Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16:1736-1744
10. Allendorf JD, Lauerman M, Bill A et al (2008) Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival. J Gastrointestinal Surg 12:91-100
11. Katz MHG, Pisters PWT, Evans DB et al (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206:833-848
12. Tzeng CWD, Fleming JB, Lee JE et al (2012) Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. Ann Surg Oncol 19:2045-2053
13. Chun YS, Milestone BN, Watson JC et al (2010) Defining venous involvement in borderline resectable pancreatic cancer. Ann Surg Oncol 17:2832-2838
14. Pancreatic adenocarcinoma version 2 (2012) NCCN Clinical Practice Guidelines in Oncology, 2012. http://www.nccn.org/professionals/physician-gls/f- guidelines.asp#pancreatic. Accessed 15 Oct 2013
15. DeOliveira ML, Winter JM, Schafer M et al (2006) Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 244:931-939
16. Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8-13
17. Schnelldorfer T, Ware AL, Sarr MG et al (2008) Long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg 247:456-462
18. Assifi MM, Lu X, Eibl G et al (2011) Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials. Surgery 150:466-473
19. Ramacciato G, Mercantini P, Petrucciani N et al (2009) Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? Ann Surg Oncol 16:817-825
20. Barugola G, Partelli S, Crippa S et al (2012) Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. Am J Surg 203:132-139
21. Bockhorn M, Burdelski C, Bogoevski D et al (2011) Arterial en bloc resection for pancreatic carcinoma. Br J Surg 98:86-92
22. Mollberg N, Rahbari NN, Koch M et al (2011) Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 254:882-893
23. Tseng JF, Raut CP, Lee JE et al (2004) Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8:935-950
24. Yekebas EF, Bogoevski D, Cataldegirmen G et al (2008) En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 247:300-309
25. Zhou Y, Zhang Z, Liu Y et al (2012) Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis. World J Surg 36:884-891. doi: 10.1007/s00268-012-1461-z
26. Kang CM, Chung YE, Park JY et al (2012) Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer. J Gastrointest Surg 16:509-517
27. Morganti AG, Massaccesi M, La Torre G et al (2010) A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. Ann Surg Oncol 17:194-205